- Employment (105)
- Litigation / Dispute Resolution (87)
- Company/Commercial (81)
- Corporate (46)
- Banking / Finance (38)
- Regulatory and compliance (28)
- Financial services (20)
- Competition/EU (19)
- Pharma/Biotech (18)
- Information Technology (17)
- Intellectual Property (15)
- Media/Entertainment/Sport (15)
- Tax (11)
- Crime (10)
- Healthcare (10)
- Energy (9)
- Funds (9)
- Telecoms (8)
- Environment (6)
- Insurance/reinsurance (6)
- Insolvency & restructuring (5)
- Other (5)
- Commodities (4)
- Pensions (3)
- Agriculture (2)
- Family (2)
- Human Rights (2)
- Immigration (2)
- Private Equity (2)
- Public Sector/Local Authority (2)
- Real Estate (2)
- Travel and Tourism (2)
- Business Tax (1)
- Charities (1)
- Construction (1)
- Personal Injury (1)
- Personal tax / Trusts (1)
- Suppliers (1)
- Transport (Including aviation and shipping) (1)
Sort By: Newest first | Oldest first
Companies in the federal supply chain have an opportunity to prepare for the expansion of government’s anti-human-trafficking rules
This update highlights the salient aspects of the proposed rules and the requirements that are likely to be of most interest to contractors.
Companies should assess their business operations and relationships in Ukraine.
The new compensation limits for dismissals taking place on or after 6 April 2014 have been published.
Ever since the Equality Act came in, there has been uncertainty as to whether it covers post-employment victimisation.
The EAT had to decide two main issues: had the claimant made a ‘disclosure’? Did he suffer detriment as a result of that?
FDA revises forms for submission of patent information to the Orange Book: Federal Circuit decision alters patent term adjustment
Two recent developments will affect the listing of patent information with pharmaceutical products approved by the US Food and Drug Administration.
This guide details the thresholds for a variety of taxes, both personal and business, in South Africa from 1 March 2014 onwards.
The claimant in The Solicitors Regulation Authority v Mitchell had agreed with her employers that she could work from home two days each week to facilitate childcare arrangements.
NYAG forges new ground in scrutiny of pharmaceutical agreements with first-filer exclusivity no-challenge settlement
NYAG has reached a settlement with two drug manufacturers regarding allegations that an agreement between the firms not to challenge each other’s eligibility for regulatory exclusivity was anti-competitive.
A section in last year’s Enterprise and Regulatory Reform Act is coming into force for claims started on or after 6 April.